Rhein-Main Cancer Retreat 2024
At this years 5th Rhein-Main Cancer Retreat in Glasshütte the leukemia research group contributed with three outstanding talks by our group leaders, which were accompanied by a total of seven posters.
Frankfurt Cancer Conference
Welcoming us and international experts the UCT, FCI and the DKTK with their cutting edge conference about cancer research. Filled with exiting talks and posters, held at the Westend Campus of the Goethe-University.
1.5 Mio € research funding awarded to Marit and Hannah
Awarded as the newest members of the Max-Eder-Nachwuchsprogramm junior group leaders Marit and Hannah received a combined amount of 1.5 mio Euros in funding to support their research aims.
Commentary: MYC-stery of Down syndrome unravelled
A commentary giving insights on Sato et al.'s comprehensive genomic analysis and functional validation. A study advancing our understanding of the genetic factors that influence TAM to ML-DS progression.
Annual Meeting of the European Hematology Association in Madrid
Our research group being represented at EHA 2024 with three presentations and two posters, sharing our work on pediatric leukemia.
Annual Kind-Phillip-Meeting in Wilsede 2024
Like every year the leukemia research group makes it way to the north of Germany for the annual Kind-Phillip-Meeting for an insightful conference about pediatric cancers.
Leukemia research on Television
The latest episode of a regional news outlet on German television network SAT.1 featured Prof.Klusmann and Prof.Heckl. The interview gives insights on possible applications of micro RNAs in cancer therapies.
Luca wins Abstract Award at ASH 2023
Luca was awarded with the abstract award and presents his work at this years annual meeting of the American Society of Hematology in San Diego.
Myeloid leukemia vulnerabilities embedded in long non-coding RNA locus MYNRL15
Publication alert: The identification of long non-coding RNA locus MYNRL15 shows novel therapeutic potential in AMLs with various genetic backgrounds.
Prof. Dirk Heckl Director of the institute for Experimental Paediatric Haematology and Oncology
Prof. Dirk Heckl takes on a new position and joins the rest of the leukemia research team in Frankfurt.